ACCESS Health successfully collaborated with ASK Health Asia for the Asia Health and Life Sciences Innovation and Cooperation Summit 2023. At this event, Dr Krishna Reddy Nallamalla, President, Asia, ACCESS Health International, moderated the opening panel. This panel discussion revolved around the essential theme of cross-regional commitment to health in a world shaped by the aftermath of the pandemic, and it involved the active participation of accomplished panellists.

The discussions yielded valuable insights, including: The imperative need for collaborative efforts spanning clinicians, civil society, academia, industry, governmental bodies, the private sector, and philanthropic organizations.

The panel Dr. Reddy moderated comprised of:

Sylvia Varela, Asia Area Vice President at AstraZeneca

Diah Satyani Saminarsih, Founder and Chief Executive Officer, Center for Indonesia’s Strategic Development Initiatives (CISDI)

Naina Subberwal Batra, CEO, AVPN

Dr. Dinesh Arora, Principal Health Specialist, Asian Development Bank (ADB)

Kotaro Tamura, Adjunct Professor, Lee Kuan Yew School of Public Policy; Chairman, Ecosphere

This panel discussion was part of a wider topic titled “Market Opportunities for Life Sciences Innovation in Asia” where ACCESS Health International was a Session Partner alongside AstraZeneca.  A call for health systems to adopt a people-centric approach. Civil society’s critical role in delivering healthcare, particularly in areas with limited services, was underscored. It was emphasized that understanding the unique challenges faced by marginalized populations is crucial to identifying gaps and developing tailored innovations to serve their specific needs.

The urgency of forging collaborations and partnerships to bridge the staggering estimated annual financing gap of $371 billion, a point highlighted by AVPN CEO Naina Subberwal Batra.

Sylvia Varela, Vice-President of AstraZeneca Asia, shed light on the pivotal role of Artificial Intelligence (AI) in enhancing healthcare delivery, particularly in early detection and prevention of non-communicable diseases like COPD and lung cancer.

The key takeaways of this discussion align seamlessly with ACCESS Health International’s mission on a global scale and we are happy to be a part and an active contributor to such imperative conversations.

Share This